(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone

C45H66ClN5O10 — CID 23232946

IUPAC(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
SMILESC=C[C@]12OC(=O)N(CCCCn3cnc(-c4ccc(Cl)nc4)c3C)[C@H]1[C@H](C)C(=O)[C@H](C)C[C@](C)(OC)[C@H](OC1O[C@H](C)C[C@H](N(C)C)[C@H]1O)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H]2CC
InChIInChI=1S/C45H66ClN5O10/c1-13-33-45(14-2)39(51(43(56)61-45)20-16-15-19-50-24-48-35(30(50)8)31-17-18-34(46)47-23-31)27(5)36(52)25(3)22-44(9,57-12)40(28(6)37(53)29(7)41(55)59-33)60-42-38(54)32(49(10)11)21-26(4)58-42/h14,17-18,23-29,32-33,38-40,42,54H,2,13,15-16,19-22H2,1,3-12H3/t25-,26-,27-,28+,29-,32+,33+,38-,39+,40-,42?,44+,45-/m1/s1
InChIKeyKASPGAMENIHAEO-IDDYPYOBSA-N
MW872.50 g/mol
LogP6.06
Rot. Bonds12

About (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone

(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (PubChem CID 23232946) has the molecular formula C45H66ClN5O10 and a molecular weight of 872.50 g/mol. Its IUPAC name is (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone.

Molecular Properties

Compound Name(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
PubChem CID23232946
Molecular FormulaC45H66ClN5O10
Molecular Weight872.50 g/mol
Exact Mass871.45
IUPAC Name(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
SMILESC=C[C@]12OC(=O)N(CCCCn3cnc(-c4ccc(Cl)nc4)c3C)[C@H]1[C@H](C)C(=O)[C@H](C)C[C@](C)(OC)[C@H](OC1O[C@H](C)C[C@H](N(C)C)[C@H]1O)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H]2CC
InChIInChI=1S/C45H66ClN5O10/c1-13-33-45(14-2)39(51(43(56)61-45)20-16-15-19-50-24-48-35(30(50)8)31-17-18-34(46)47-23-31)27(5)36(52)25(3)22-44(9,57-12)40(28(6)37(53)29(7)41(55)59-33)60-42-38(54)32(49(10)11)21-26(4)58-42/h14,17-18,23-29,32-33,38-40,42,54H,2,13,15-16,19-22H2,1,3-12H3/t25-,26-,27-,28+,29-,32+,33+,38-,39+,40-,42?,44+,45-/m1/s1
InChIKeyKASPGAMENIHAEO-IDDYPYOBSA-N
XLogP6.06
TPSA171.85 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds12
Heavy Atoms61
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500872.50
LogP ≤ 56.06
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The IUPAC name of (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone (CID 23232946) is (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone.
What is the SMILES notation for (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The canonical SMILES for (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone is C=C[C@]12OC(=O)N(CCCCn3cnc(-c4ccc(Cl)nc4)c3C)[C@H]1[C@H](C)C(=O)[C@H](C)C[C@](C)(OC)[C@H](OC1O[C@H](C)C[C@H](N(C)C)[C@H]1O)[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H]2CC.
What is the InChIKey of (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
The InChIKey is KASPGAMENIHAEO-IDDYPYOBSA-N. The full InChI is InChI=1S/C45H66ClN5O10/c1-13-33-45(14-2)39(51(43(56)61-45)20-16-15-19-50-24-48-35(30(50)8)31-17-18-34(46)47-23-31)27(5)36(52)25(3)22-44(9,57-12)40(28(6)37(53)29(7)41(55)59-33)60-42-38(54)32(49(10)11)21-26(4)58-42/h14,17-18,23-29,32-33,38-40,42,54H,2,13,15-16,19-22H2,1,3-12H3/t25-,26-,27-,28+,29-,32+,33+,38-,39+,40-,42?,44+,45-/m1/s1.
What are the key properties of (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone?
(1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone has a molecular weight of 872.50 g/mol, XLogP of 6.06, 12 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,2S,5R,7R,8R,9S,11R,13S,14S)-15-[4-[4-(6-chloro-3-pyridinyl)-5-methylimidazol-1-yl]butyl]-8-[(3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-1-ethenyl-2-ethyl-9-methoxy-5,7,9,11,13-pentamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone is sourced from PubChem (CID 23232946), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).